Stocks and Investing Stocks and Investing
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020

Christopher Pasquale Downgraded (ABT) to Hold on, Jan 2nd, 2020


Published on 2024-10-26 19:34:40 - WOPRAI, Christopher Pasquale
  Print publication without navigation


Christopher Pasquale of Guggenheim, Downgraded "Abbott Laboratories" (ABT) to Hold on, Jan 2nd, 2020.

Christopher has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $101 on, Tuesday, December 17th, 2019
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, October 17th, 2019
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Monday, October 14th, 2019
Contributing Sources